EVALUATION OF C-REACTIVE PROTEINS IN BENIGN PROSTATIC HYPERPLASIA (BPH) SUBJECTS

  • I.N. Nnatuanya Madonna University Nigeria, Elele Campus, Rivers State
  • Emmanuel Ifeanyi Obeagu Madonna University Nigeria, Elele Campus, Rivers State
  • Arvin Nwakulite Madonna University Nigeria, Elele Campus, Rivers State
  • Chikaeme Agatha Hezekiah Madonna University Nigeria, Elele Campus, Rivers State
Keywords: c-reactive proteins, benign prostatic hyperplasia, inflammation

Abstract

This study was carried out to evaluate the levels of C-reactive protein (CRP) in benign prostatic hyperplasia (BPH) subjects in General Hospital Bwari, FCT Abuja, Nigeria.A total of fifty (50) subjects were recruited in this study. Twenty five (25) BPH subjects served as test and twenty five (25) apparently healthy subjects served as control. Fluorescence immunoassay (FIA) method for quantitative evaluation of CRP was used in this assay. The data generated from this study was statistically analysed using statistical package for social science (SPSS) version 21.0 for windows. The result showed thatthere was no significant difference (p > 0.05) in the mean concentration of C-reactive protein (CRP) (mg/L) in Benign Prostatic Hyperplasia (BPH) subjects (6.92 ± 3.62) when compared with apparently healthy subjects (5.24 ± 3.63). Hence, C-reactive protein cannot be used as a marker for the diagnosis of benign prostatic hyperplasia (BPH).

Published
2022-03-04
How to Cite
Nnatuanya, I., Obeagu, E. I., Nwakulite, A., & Hezekiah, C. A. (2022). EVALUATION OF C-REACTIVE PROTEINS IN BENIGN PROSTATIC HYPERPLASIA (BPH) SUBJECTS. Madonna University Journal of Medicine and Health Sciences ISSN: 2814-3035, 2(1), 239-248. Retrieved from https://journal.madonnauniversity.edu.ng/index.php/medicine/article/view/51
Issue
Vol 2 No 1 (2022): MJMHS
Section
Articles
Copyright (c) 2022 Madonna University journal of Medicine and Health Sciences

Most read articles by the same author(s)